Biosketch / Results /

Daniel C Cho, M.D.

Assistant Professor;
Department of Medicine (Medicine)

Clinical Addresses

160 E. 34th Street
New York, NY 10016
Handicap Access: yes
Phone: 212-731-5445

« Back to Results

Medical Specialties

Hematology, Medical Oncology

Insurance

AETNA HMO, AETNA INDEMNITY, AETNA MEDICARE, AETNA POS, AETNA PPO/EPO, AFFINITY, CIGNA EPO/POS, Cigna PPO, EBCBS EPO, EBCBS HLTHY NY, EBCBS HMO, EBCBS INDEMNITY, EBCBS MEDIBLUE, EBCBS PATHWAYS / PATHWAYS ENHANCED, EBCBS POS, EBCBS PPO, FIDELIS CHLD HLTH, FIDELIS FAM HLTH, FIDELIS MEDICARE, Fidelis Medicaid, GHI CBP, HEALTHPLUS CHLD HLTH (AMERIGROUP), HEALTHPLUS FAM HLTH (AMERIGROUP), HEALTHPLUS MEDICAID (AMERIGROUP), HEALTHREPUBLIC, HIP ACCESS I, HIP ACCESS II, HIP CHLD HLTH, HIP EPO/PPO, HIP HMO, HIP MEDICARE, HIP POS, LOCAL 1199 PPO, MAGNACARE PPO, METROPLUS CHLD HLTH, METROPLUS FAM HLTH, MULTIPLAN/PHCS PPO, Medicare, MetroPlus Medicaid, OSCAR, OXFORD EXCHANGE, OXFORD FREEDOM, Oxford Liberty, Oxford Medicare, Tricare, UHC COMMUNITY & STATE PLAN, UHC EPO, UHC HMO, UHC MEDICARE, UHC POS UHC PPO, UHC TOP TIER, UNITED EXCHANGE- COMPASS, WELLCARE CHLD HLTH, WELLCARE FAM HLTH, WELLCARE MEDICAID, WELLCARE MEDICARE

Insurance Disclaimer: Insurance listed above may not be accepted at all office locations. Please confirm prior to each visit. The information presented here may not be complete or may have changed.

« Back to Results

Board Certification

2003 — Ab Internal Medicine - Internal Medicine
2006 — Ab Internal Medicine (Medical Oncology)

Education

1996-2000 — Washington University in St. Louis School of Medicine, Medical Education
2000-2001 — Beth Israel Deaconess Med Ctr (Internal Medicine), Internship
2000-2001 — Beth Israel Deaconess Med Ctr (No Value Specified), Internship
2000-2003 — Beth Israel Deaconess Med Ctr (No Value Specified), Internship
2001-2002 — Beth Israel Deaconess Med Ctr (No Value Specified), Residency Training
2001-2003 — Beth Israel Deaconess Med Ctr (Internal Medicine), Residency Training
2002-2003 — Beth Israel Deaconess Med Ctr (No Value Specified), Clinical Fellowships
2003-2006 — Beth Israel Deaconess Med Ctr (No Value Specified), Clinical Fellowships

« Back to Results

All data from NYU Health Sciences Library Faculty Bibliography — -

Contact:
http://hsl.med.nyu.edu/faculty-bibliography-search

Targeting the PI3K/Akt/mTOR pathway in malignancy: rationale and clinical outlook
Cho, Daniel C
2014 Aug;28(4):373-381, Biodrugs
— id: 1341662, year: 2014, vol: 28, page: 373, stat: Journal Article,

Prognostic biomarkers for patients with advanced renal cell carcinoma treated with VEGF-targeted tyrosine kinase inhibitors
Cho, Daniel C
2013 ;6:679-684, OncoTargets & therapy
— id: 674202, year: 2013, vol: 6, page: 679, stat: Journal Article,

Therapeutic challenges in advanced renal cell carcinoma
Cho, Daniel C
2013 Jan;10(1):39-46, Clinical practice
— id: 674252, year: 2013, vol: 10, page: 39, stat: Journal Article,

Dual inhibition of PI3-kinase and mTOR in renal cell carcinoma
Cho, Daniel C; Mier, James W
2013 Feb;13(2):126-142, Current cancer drug targets
— id: 674232, year: 2013, vol: 13, page: 126, stat: Journal Article,

A phase 1 open-label, sequential dose-escalation study investigating the safety, tolerability, and pharmacokinetics of intravenous TLC388 administered to patients with advanced solid tumors
Ghamande, Sharad; Lin, Chia-Chi; Cho, Daniel C; Shapiro, Geoffrey I; Kwak, Eunice L; Silverman, Michael H; Tseng, Yunlong; Kuo, Min-Wen; Mach, Wendy B; Hsu, Shu-Chi; Coleman, Teresa; Yang, James Chih-Hsin; Cheng, Ann-Lii; Ghalib, Mohammad H; Chuadhary, Imran; Goel, Sanjay
2013 Nov;:445-451, Investigational new drugs
— id: 674182, year: 2013, vol: , page: 445, stat: Journal Article,

Vemurafenib-induced cardiac tamponade: a rare but potentially life-threatening complication
Mahoney, Kathleen M; Ackerman, Allison; Cho, Daniel C; McDermott, David F; Peters, Toni; Atkins, Michael B
2013 Jul;31(21):e364-e366, Journal of clinical oncology
— id: 674192, year: 2013, vol: 31, page: e364, stat: Journal Article,

Perifosine in renal cell carcinoma
Srivastava, Neeharika; Cho, Daniel C
2013 Feb;22(2):285-291, Expert opinion on investigational drugs
— id: 674242, year: 2013, vol: 22, page: 285, stat: Journal Article,

First-in-humans trial of an RNA interference therapeutic targeting VEGF and KSP in cancer patients with liver involvement
Tabernero, Josep; Shapiro, Geoffrey I; LoRusso, Patricia M; Cervantes, Andres; Schwartz, Gary K; Weiss, Glen J; Paz-Ares, Luis; Cho, Daniel C; Infante, Jeffrey R; Alsina, Maria; Gounder, Mrinal M; Falzone, Rick; Harrop, Jamie; White, Amy C Seila; Toudjarska, Iva; Bumcrot, David; Meyers, Rachel E; Hinkle, Gregory; Svrzikapa, Nenad; Hutabarat, Renta M; Clausen, Valerie A; Cehelsky, Jeffrey; Nochur, Saraswathy V; Gamba-Vitalo, Christina; Vaishnaw, Akshay K; Sah, Dinah W Y; Gollob, Jared A; Burris, Howard A 3rd
2013 Apr;3(4):406-417, Cancer discovery
— id: 674212, year: 2013, vol: 3, page: 406, stat: Journal Article,

PI3K inhibition potentiates Bcl-2-dependent apoptosis in renal carcinoma cells
Zhu, Shudong; Cohen, Matthew B; Bjorge, Jeffrey D; Mier, James W; Cho, Daniel C
2013 Mar;17(3):377-385, Journal of cellular & molecular medicine
— id: 674222, year: 2013, vol: 17, page: 377, stat: Journal Article,

Serum cholesterol and mTOR inhibitors: surrogate biomarker or epiphenomenon?
Cho, Daniel C; Atkins, Michael B
2012 Jun;18(11):2999-3001, Clinical cancer research
— id: 674282, year: 2012, vol: 18, page: 2999, stat: Journal Article,

Two phase 2 trials of the novel Akt inhibitor perifosine in patients with advanced renal cell carcinoma after progression on vascular endothelial growth factor-targeted therapy
Cho, Daniel C; Hutson, Thomas E; Samlowski, Wolfram; Sportelli, Peter; Somer, Brad; Richards, Paul; Sosman, Jeffrey A; Puzanov, Igor; Michaelson, M Dror; Flaherty, Keith T; Figlin, Robert A; Vogelzang, Nicholas J
2012 Dec;118(24):6055-6062, Cancer
— id: 674262, year: 2012, vol: 118, page: 6055, stat: Journal Article,

Pneumonitis associated with mTOR inhibitors therapy in patients with metastatic renal cell carcinoma: incidence, radiographic findings and correlation with clinical outcome
Dabydeen, Donnette A; Jagannathan, Jyothi P; Ramaiya, Nikhil; Krajewski, Katherine; Schutz, Fabio A B; Cho, Daniel C; Pedrosa, Ivan; Choueiri, Toni K
2012 Jul;48(10):1519-1524, European journal of cancer (1990)
— id: 674272, year: 2012, vol: 48, page: 1519, stat: Journal Article,

mTOR inhibitors in renal cell carcinoma
Battelli, Chiara; Cho, Daniel C
2011 Jul;8(4):359-367, Therapy
— id: 674322, year: 2011, vol: 8, page: 359, stat: Journal Article,

Future directions in renal cell carcinoma: 2011 and beyond
Cho, Daniel C; Atkins, Michael B
2011 Aug;25(4):917-935, Hematology-oncology clinics of North America
— id: 674312, year: 2011, vol: 25, page: 917, stat: Journal Article,

Predictors of response to sequential sunitinib and the impact of prior VEGF-targeted drug washout in patients with metastatic clear-cell renal cell carcinoma
Elfiky, Aymen A; Cho, Daniel C; McDermott, David F; Rosenberg, Jonathan E; Fortner, Barry; Antras, Lucia; Chen, Kristina; Sheng Duh, Mei; Jayawant, Sujata S; Oh, William K; Atkins, Michael B; Choueiri, Toni K
2011 Nov-Dec;29(6):756-763, Urologic oncology
— id: 674292, year: 2011, vol: 29, page: 756, stat: Journal Article,

Addition of gemcitabine at the time of sunitinib resistance in metastatic renal cell cancer
Pandya, Shuchi S; Mier, James W; McDermott, David F; Cho, Daniel C
2011 Oct;108(8 Pt 2):E245-E249, BJU international
— id: 674302, year: 2011, vol: 108, page: E245, stat: Journal Article,

The efficacy of the novel dual PI3-kinase/mTOR inhibitor NVP-BEZ235 compared with rapamycin in renal cell carcinoma
Cho, Daniel C; Cohen, Matthew B; Panka, David J; Collins, Michael; Ghebremichael, Musie; Atkins, Michael B; Signoretti, Sabina; Mier, James W
2010 Jul;16(14):3628-3638, Clinical cancer research
— id: 674342, year: 2010, vol: 16, page: 3628, stat: Journal Article,

Carbonic anhydrase IX and pathological features as predictors of outcome in patients with metastatic clear-cell renal cell carcinoma receiving vascular endothelial growth factor-targeted therapy
Choueiri, Toni K; Regan, Meredith M; Rosenberg, Jonathan E; Oh, William K; Clement, Jessica; Amato, Angela M; McDermott, David; Cho, Daniel C; Atkins, Michael B; Signoretti, Sabina
2010 Sep;106(6):772-778, BJU international
— id: 674332, year: 2010, vol: 106, page: 772, stat: Journal Article,

Retrospective analysis of the safety and efficacy of interleukin-2 after prior VEGF-targeted therapy in patients with advanced renal cell carcinoma
Cho, Daniel C; Puzanov, Igor; Regan, Meredith M; Schwarzberg, Talya; Seery, Virginia; Lee, Mee-Young; Liu, Vivian; Bhatt, Rupal; Koon, Henry; Mier, James W; Sosman, Jeffrey A; Atkins, Michael B; McDermott, David F
2009 Feb-Mar;32(2):181-185, Journal of immunotherapy (Hagerstown)
— id: 674352, year: 2009, vol: 32, page: 181, stat: Journal Article,

GSK-3beta inhibition enhances sorafenib-induced apoptosis in melanoma cell lines
Panka, David J; Cho, Daniel C; Atkins, Michael B; Mier, James W
2008 Jan;283(2):726-732, Journal of biological chemistry
— id: 674362, year: 2008, vol: 283, page: 726, stat: Journal Article,